PEAK6 Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-5,400
Closed -$643K 4273
2018
Q1
$643K Sell
5,400
-32,100
-86% -$4.14M 0.02% 2350
2017
Q4
$4.76M Sell
37,500
-14,100
-27% -$1.77M 0.16% 841
2017
Q3
$6.06M Buy
51,600
+34,100
+195% +$2.91M 0.25% 643
2017
Q2
$1.4M Hold
17,500
0.06% 1642
2017
Q1
$897K Sell
17,500
-100
-0.6% -$4.62K 0.05% 1776
2016
Q4
$659K Sell
17,600
-22,300
-56% -$934K 0.03% 2245
2016
Q3
$2.7M Buy
39,900
+16,100
+68% +$1.14M 0.15% 1070
2016
Q2
$1.32M Buy
23,800
+16,700
+235% +$1.05M 0.08% 1571
2016
Q1
$446K Buy
+7,100
New +$472K 0.03% 2378
2015
Q4
Sell
-10,000
Closed -$804K 4696
2015
Q3
$804K Sell
10,000
-600
-6% -$66.7K 0.03% 2430
2015
Q2
$1.27M Buy
10,600
+7,600
+253% +$908K 0.05% 1866
2015
Q1
$313K Sell
3,000
-13,100
-81% -$1.33M 0.01% 3031
2014
Q4
$1.56M Buy
16,100
+12,600
+360% +$1.17M 0.06% 1572
2014
Q3
$273K Buy
+3,500
New +$226K 0.01% 3027
2014
Q2
Sell
-5,000
Closed -$336K 4579
2014
Q1
$336K Buy
+5,000
New +$387K 0.01% 2923
2013
Q4
Sell
-11,600
Closed -$371K 4856
2013
Q3
$371K Buy
11,600
+1,500
+15% +$74.8K 0.01% 3086
2013
Q2
$313 Buy
+10,100
New +$269K ﹤0.01% 3223

Other funds holding ALNY